ArticleCureus2025
Percutaneous Computed Tomography (CT)-Guided Biopsy of Focal Chest Wall Lesions: A Retrospective Cohort Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to retrospectively evaluate the efficiency, accuracy, technical features, and relationships among the monitored parameters of CT-guided percutaneous biopsies of focal chest wall lesions. METHODOLOGY: A total of 143 percutaneous biopsy procedures for tumors, ranging in size from 15 to 168 mm (median size 43 mm), were performed in patients with focal chest wall lesions over 12 years. Only local anesthesia using trimecaine was sufficient for the procedures. The duration of the intervention never exceeded 20 minutes. Needles 14 G, 16 G, or 18 G were used for the biopsies. Histological results were extended with subtyping in the vast majority of cases. In 91 interventions (63.6%), malignant disease was present in the patients´ medical history.
resultsDiagnostic accuracy was achieved in 137 (95.8%) biopsies, while six (4.2%) procedures yielded false-negative histological results later confirmed by surgical excision. Metastatic disease of diverse origins represented the most frequent histological diagnosis (46.2%). Hematologic malignancies were revealed in 29.4% of procedures. Primary tumors were verified in only 13 (9.1%) cases. Complications occurred in 3 (2.1%) procedures, all consisting of minor hemorrhage managed conservatively.
conclusionCT-guided percutaneous core needle biopsy of focal chest wall lesions demonstrated high diagnostic accuracy with a minimal incidence of complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.